Glialogix has partnered with the National Multiple Sclerosis Society’s Fast Forward nonprofit to develop treatment therapies for progressive MS, including the acceleration of clinical trials of its GLX1112 oral therapy.

READ FULL ARTICLE Curated publisher From PharmiWeb.com